Headlines to cover at the AAAS Annual Meeting in Austin, Texas

January 09, 2018

PRESS REGISTRATION:

Credentialed Reporters and Public Information Officers May Register Here: https://www.eurekalert.org/aaasnewsroom/2018/registration/

AUSTIN, TEXAS--Regenerating organs for patient transplants, research and policy questions for "smart" vehicles, advances in the fight against cancer, and voter participation in elections will be discussed at the 2018 American Association for the Advancement of Science (AAAS) Annual Meeting, the world's largest general scientific conference.

Free public lectures on the International Space Station and the need for scientists to communicate more than facts in an era of fake news, plus sessions on the brain function of "super-agers," wearable sensor technology, and science-informed responses to climate change promise news at the conference.

During February 15-19 in Austin, Texas, the 184th AAAS Annual Meeting will offer free public lectures and hands-on fun for families, as well as an array of scientific and technical sessions for registrants. AAAS--publisher of the journals Science, Science Translational Medicine, Science Signaling, Science Advances, Science Robotics, and Science Immunology--anticipates up to 10,000 attendees at its first Annual Meeting to be held in Austin.

Two free Family Science Days--11:00 a.m. until 4:00 p.m., Saturday and Sunday, February 17-18--will feature hands-on science-learning activities, plus a jam-packed "Meet the Scientists" speaker series designed especially for middle- and high-school students. For details, see http://www.aaas.org/meetings/fsd/. Events will take place at the Austin Convention Center.

The theme of this year's conference, "Advancing Science: Discovery to Application," was organized by AAAS President Susan Hockfield, president emerita and professor of neuroscience at Massachusetts Institute of Technology. "We must work together with renewed energy across the full spectrum of the scientific enterprise--and across the sectors that advance it," Hockfield said. "Academia, government and industry all perform critical roles in moving ideas into innovations. Robust, sustained investments across the full spectrum of the scientific enterprise are essential for developing products that improve the human condition and drive economic growth."

As the first woman and first biologist to serve as president of Massachusetts Institute of Technology (2004-2012), Hockfield highlighted the importance of building diversity all along the talent pipeline. She fostered cross-disciplinary, cross-institutional and cross-national initiatives, among them the Koch Institute for Integrative Cancer Research, the MIT Energy Initiative and the Massachusetts Green High-Performance Computing Center, and she co-chaired the White House's Advanced Manufacturing Partnership. She avidly advocates increasing interactions across the academy, industry and government. In her research, Hockfield was among the first scientists to apply molecular biology to neuroscience, using monoclonal antibodies to study brain structure and development. She demonstrated that early experience leads to lasting changes in the molecular structure of the brain and discovered a gene involved in the spread of brain cancer cells into healthy brain tissue.

Free Public Lectures

The meeting will officially kickoff on Thursday, February 15 with the AAAS president's lecture at 6:00 p.m. Public lectures will take place at the Austin Convention Center, Ballroom D.

On Friday, February 16 at 5:15 p.m., astronaut Ellen Ochoa, director of NASA's Johnson Space Center, will discuss "The International Space Station: A Laboratory in Space."

At 5:15 p.m. on Saturday, February 17, geneticist Cori Bargmann, president of Chan Zuckerberg Science, will present "The Chan Zuckerberg Initiative: Accelerating Science."

On Sunday, February 18 at 5:15 p.m., atmospheric scientist Katharine Hayhoe, director of the Climate Science Center at Texas Tech University, will discuss "When Facts Are Not Enough."

Science News Opportunities

Highlights from the meeting will include these and many other breaking research news topics: Reporters can contact AAAS to receive advance information about two-dozen embargoed press briefings and related social events for credentialed newsroom registrants.

The news briefing lineup will kick off Thursday, February 15 with a reporters-only press breakfast hosted by AAAS President Susan Hockfield, followed by the release of new research from the journal Science.

Meet the Scientists During Family Science Days

PHOTO / TV OPPORTUNITIES (Video Available) http://www.aaas.org/meetings/fsd/


Free AAAS Family Science Days--scheduled for 11:00 a.m. to 4:00 p.m. on Saturday and Sunday, February 17-18 at the Austin Convention Center--will include hands-on activities and stage shows for families with children, teenagers, and young adults. To attend, register in advance via the website above. Walk-in registration is also available on-site.

Family Science Days participants will have the opportunity to:Scientific Program for Registrants

In addition to free public offerings, registrants to the AAAS Annual Meeting will be able to sample a diversity of symposia, seminars, and lectures covering more than 120 topics encompassing engineering and technology; communication, language and culture; climate and the environment; medicine and health; physics and astronomy; science education; and more.

Topical lectures will include discussions on the responsibility of the scientific community to address sexual harassment by Meg Urry of Yale University; solutions to the opioid crisis by Nora Volkow, director of the National Institute on Drug Abuse; the future of science in Africa by Thomas Kariuki of the African Academy of Sciences; forensic science and the law by federal district judge Jed Rakoff; music for brain health by Nina Kraus of Northwestern University; the violence of migration by anthropologist Jason De León of the University of Michigan; and more. See http://meetings.aaas.org/program for the full meeting program.
-end-
MEDIA NOTE: On-site registration for journalists opens at 7:00 a.m. on Thursday, February 15, in the Austin Convention Center, Level 3, Room 7. The AAAS President's press breakfast will begin at 7:45 a.m., followed by the first news briefing at 9:00 a.m. Additional information on

AAAS Annual Meeting news offerings can be provided in advance to reporters who ensure adherence to the embargo policy. Embargoed news will be available to reporters via the AAAS virtual newsroom, online at EurekAlert! beginning Monday, February 12.

This news release contains general, publicly available information about this year's program, and is therefore appropriate for immediate release.

About the American Association for the Advancement of Science

The American Association for the Advancement of Science (AAAS) is the world's largest general scientific society and publisher of the journal Science, as well as Science Translational Medicine; Science Signaling; a digital, open-access journal Science Advances; Science Immunology; and Science Robotics. AAAS was founded in 1848 and includes nearly 250 affiliated societies and academies of science, serving 10 million individuals. Science has the largest paid circulation of any peer-reviewed general science journal in the world. The nonprofit AAAS is open to all and fulfills its mission to "advance science and serve society" through initiatives in science policy, international programs, science education, public engagement and more. For the latest research news, log onto EurekAlert!, the premier science-news website, a service of AAAS.

American Association for the Advancement of Science

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.